undamentalytics Newsletter
Sign in

Cvrx, Inc. income statement

In fiscal 2025, Cvrx, Inc. reported revenue of $56.7m, up 10.4% on the year before, operating income of −$51.3m (a -90.5% margin) and net income of −$53.3m, or −$2.04 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue6132239515761
Cost of revenue1456888
Gross profit591733434853
Research and development681012111112
Selling, general and administrative10285065918889
Operating income−12−26−43−43−59−51−49
Interest expense2202466
Income before tax−14−43−41−41−60−53−52
Income tax00000−0−0
Net income−14−43−41−41−60−53−52
Diluted EPS−$18.50−$2.08−$2.02−$1.99−$2.65−$2.04−$1.97
Diluted shares (average)—21m21m21m23m26m26m
EBITDA−11−26−42−43−59−51−48

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: APT vs CVRXCVRX vs LNSRAPYX vs CVRX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Cvrx, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cvrx, Inc.